{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:37:21Z","timestamp":1792305441201,"version":"4.4.0"},"reference-count":47,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:sec id=\"ab-jus230012-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Neural tube defects are among the most common birth defects in the US.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jus230012-2\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To review new evidence on the benefits and harms of folic acid supplementation for the prevention of neural tube defects to inform the US Preventive Services Task Force.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jus230012-3\">\n                    <jats:title>Evidence Review<\/jats:title>\n                    <jats:p>Sources included PubMed, Cochrane Library, Embase, and trial registries from July 1, 2015, through July 2, 2021; references; and experts, with surveillance through February 10, 2023. Two investigators independently reviewed English-language randomized studies and nonrandomized cohort studies in very highly developed countries that focused on the use of folic acid supplementation for the prevention of neural tube defect\u2013affected pregnancies; methodological quality was dually and independently assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jus230012-4\">\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Twelve observational studies (reported in 13 publications) were eligible for this limited update (N\u2009=\u20091\u202f244\u202f072). Of these, 3 studies (n\u2009=\u2009990\u202f372) reported on the effect of folic acid supplementation on neural tube defects. For harms, 9 studies were eligible: 1 randomized clinical trial (n\u2009=\u2009431) reported on variations in twin delivery, 7 observational studies (n\u2009=\u2009761\u202f125) reported on the incidence of autism spectrum disorder, and 1 observational study (n\u2009=\u2009429\u202f004) reported on maternal cancer. Two cohort studies and 1 case-control study newly identified in this update reported on the association between folic acid supplementation and neural tube defects (n\u2009=\u2009990\u202f372). One cohort study reported a statistically significant reduced risk of neural tube defects associated with folic acid supplementation taken before pregnancy (adjusted relative risk [aRR], 0.54 [95% CI, 0.31-0.91]), during pregnancy (aRR, 0.62 [95% CI, 0.39-0.97]), and before and during pregnancy (aRR, 0.49 [95% CI, 0.29-0.83]), but this association occurred for only the later of 2 periods studied (2006-2013 and not 1999-2005). No other statistically significant benefits were reported overall. No study reported statistically significant harms (multiple gestation, autism, and maternal cancer) associated with pregnancy-related folic acid exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jus230012-5\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>New evidence from observational studies provided additional evidence of the benefit of folic acid supplementation for preventing neural tube defects and no evidence of harms related to multiple gestation, autism, or maternal cancer. The new evidence was consistent with previously reviewed evidence on benefits and harms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2023.9864","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T11:01:29Z","timestamp":1690887689000},"page":"460","source":"Crossref","is-referenced-by-count":90,"title":["Folic Acid Supplementation to Prevent Neural Tube Defects"],"prefix":"10.1001","volume":"330","author":[{"given":"Meera","family":"Viswanathan","sequence":"first","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center"},{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Peragallo","family":"Urrutia","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesha N.","family":"Hudson","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center"},{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Cook","family":"Middleton","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center"},{"name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila C.","family":"Kahwati","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center"},{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"jus230012r1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2016.19438","article-title":"Folic acid supplementation for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement.","volume":"317","author":"US Preventive Services Task Force","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"jus230012r5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/cga.2019.59.issue-4","article-title":"Preconception folic acid supplementation use and the occurrence of neural tube defects in Japan: a nationwide birth cohort study of the Japan Environment and Children\u2019s Study.","volume":"59","author":"Nishigori","year":"2019","journal-title":"Congenit Anom (Kyoto)"},{"issue":"6","key":"jus230012r6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1177\/1403494816649494","article-title":"Maternal use of folic acid supplements and infant risk of neural tube defects in Norway 1999-2013.","volume":"44","author":"Gildestad","year":"2016","journal-title":"Scand J Public Health"},{"issue":"3","key":"jus230012r7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1017\/S0007114520001178","article-title":"Maternal use of folic acid and multivitamin supplements and infant risk of birth defects in Norway, 1999-2013.","volume":"124","author":"Gildestad","year":"2020","journal-title":"Br J Nutr"},{"issue":"19","key":"jus230012r8","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/bdr2.v111.19","article-title":"Periconceptional folic acid and risk for neural tube defects among higher risk pregnancies.","volume":"111","author":"Petersen","year":"2019","journal-title":"Birth Defects Res"},{"issue":"12","key":"jus230012r9","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.3390\/nu13124422","article-title":"Efficacy of 4.0 mg versus 0.4 mg folic acid supplementation on the reproductive outcomes: a randomized controlled trial.","volume":"13","author":"Bortolus","year":"2021","journal-title":"Nutrients"},{"issue":"6","key":"jus230012r10","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1017\/S0033291717002410","article-title":"Research letter: folic acid supplementation and intake of folate in pregnancy in relation to offspring risk of autism spectrum disorder.","volume":"48","author":"Str\u00f8m","year":"2018","journal-title":"Psychol Med"},{"issue":"6","key":"jus230012r11","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1177\/1362361315604076","article-title":"Preconceptional and prenatal supplementary folic acid and multivitamin intake and autism spectrum disorders.","volume":"20","author":"Virk","year":"2016","journal-title":"Autism"},{"issue":"6","key":"jus230012r12","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/jama.2012.155925","article-title":"Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children.","volume":"309","author":"Sur\u00e9n","year":"2013","journal-title":"JAMA"},{"key":"jus230012r13","doi-asserted-by":"publisher","first-page":"j4273","DOI":"10.1136\/bmj.j4273","article-title":"Antenatal nutritional supplementation and autism spectrum disorders in the Stockholm youth cohort: population based cohort study.","volume":"359","author":"DeVilbiss","year":"2017","journal-title":"BMJ"},{"issue":"6","key":"jus230012r14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/ppe.2013.27.issue-6","article-title":"Analysis of self-selection bias in a population-based cohort study of autism spectrum disorders.","volume":"27","author":"Nilsen","year":"2013","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"2","key":"jus230012r15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamapsychiatry.2017.4050","article-title":"Association of maternal use of folic acid and multivitamin supplements in the periods before and during pregnancy with the risk of autism spectrum disorder in offspring.","volume":"75","author":"Levine","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"jus230012r16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.reprotox.2019.07.083","article-title":"High dose folic acid during pregnancy and the risk of autism: the birth order bias: a nested case-control study.","volume":"89","author":"Sharman Moser","year":"2019","journal-title":"Reprod Toxicol"},{"issue":"6","key":"jus230012r17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.canep.2015.10.009","article-title":"Supplemental folic acid in pregnancy and maternal cancer risk.","volume":"39","author":"Mortensen","year":"2015","journal-title":"Cancer Epidemiol"},{"issue":"11","key":"jus230012r18","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/bdra.v70:11","article-title":"Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities.","volume":"70","author":"Czeizel","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"20","key":"jus230012r19","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1001\/jama.262.20.2847","article-title":"Multivitamin\/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects.","volume":"262","author":"Milunsky","year":"1989","journal-title":"JAMA"},{"issue":"2","key":"jus230012r20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/01.EDE.0000040253.12446.B2","article-title":"Folate intake and the risk of neural tube defects: an estimation of dose-response.","volume":"14","author":"Moore","year":"2003","journal-title":"Epidemiology"},{"issue":"10","key":"jus230012r21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/aje\/153.10.961","article-title":"Neural tube defects in relation to use of folic acid antagonists during pregnancy.","volume":"153","author":"Hern\u00e1ndez-D\u00edaz","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"10","key":"jus230012r22","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1001\/jama.1993.03500100055027","article-title":"Periconceptional folic acid exposure and risk of occurrent neural tube defects.","volume":"269","author":"Werler","year":"1993","journal-title":"JAMA"},{"issue":"3","key":"jus230012r23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00001648-199505000-00005","article-title":"Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects.","volume":"6","author":"Shaw","year":"1995","journal-title":"Epidemiology"},{"issue":"7","key":"jus230012r24","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1056\/NEJM198908173210704","article-title":"The absence of a relation between the periconceptional use of vitamins and neural-tube defects.","volume":"321","author":"Mills","year":"1989","journal-title":"N Engl J Med"},{"issue":"11","key":"jus230012r25","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/aje\/152.11.1017","article-title":"Neural tube defects among Mexican Americans living on the US-Mexico border: effects of folic acid and dietary folate.","volume":"152","author":"Suarez","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"1","key":"jus230012r27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/bdra.v97.1","article-title":"Proportion of neural tube defects attributable to known risk factors.","volume":"97","author":"Agopian","year":"2013","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"1","key":"jus230012r28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/aje\/kwn331","article-title":"Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States.","volume":"169","author":"Mosley","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"3-4","key":"jus230012r29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1017\/S0001566000001938","article-title":"The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes.","volume":"43","author":"Czeizel","year":"1994","journal-title":"Acta Genet Med Gemellol (Roma)"},{"issue":"2","key":"jus230012r30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/01.ede.0000152914.84962.13","article-title":"Folate supplementation and twin pregnancies.","volume":"16","author":"Vollset","year":"2005","journal-title":"Epidemiology"},{"issue":"6","key":"jus230012r31","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1183\/09031936.00094511","article-title":"Maternal use of folic acid supplements during pregnancy, and childhood respiratory health and atopy.","volume":"39","author":"Bekkers","year":"2012","journal-title":"Eur Respir J"},{"issue":"1","key":"jus230012r32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/all.2011.67.issue-1","article-title":"The relationship between maternal folate status in pregnancy, cord blood folate levels, and allergic outcomes in early childhood.","volume":"67","author":"Dunstan","year":"2012","journal-title":"Allergy"},{"issue":"2","key":"jus230012r33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/(ISSN)1365-2222","article-title":"The association between mother and child MTHFR C677T polymorphisms, dietary folate intake and childhood atopy in a population-based, longitudinal birth cohort.","volume":"38","author":"Granell","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"jus230012r34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/adc.2008.142448","article-title":"Folic acid supplements in pregnancy and early childhood respiratory health.","volume":"94","author":"H\u00e5berg","year":"2009","journal-title":"Arch Dis Child"},{"issue":"4","key":"jus230012r35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3945\/jn.111.154948","article-title":"High circulating folate and vitamin B-12 concentrations in women during pregnancy are associated with increased prevalence of atopic dermatitis in their offspring.","volume":"142","author":"Kiefte-de Jong","year":"2012","journal-title":"J Nutr"},{"issue":"1","key":"jus230012r36","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1542\/peds.2010-1690","article-title":"Folic acid use in pregnancy and the development of atopy, asthma, and lung function in childhood.","volume":"128","author":"Magdelijns","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"jus230012r37","doi-asserted-by":"publisher","first-page":"72.e71","DOI":"10.1016\/j.ajog.2011.07.033","article-title":"Folic acid supplementation in early pregnancy and asthma in children aged 6 years.","volume":"206","author":"Martinussen","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"jus230012r38","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/aje\/kwp315","article-title":"Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study.","volume":"170","author":"Whitrow","year":"2009","journal-title":"Am J Epidemiol"},{"key":"jus230012r39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.fct.2014.11.006","article-title":"High dose of maternal folic acid supplementation is associated to infant asthma.","volume":"75","author":"Yang","year":"2015","journal-title":"Food Chem Toxicol"},{"issue":"6","key":"jus230012r40","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4168\/aair.2015.7.6.538","article-title":"Is folate status a risk factor for asthma or other allergic diseases?","volume":"7","author":"Wang","year":"2015","journal-title":"Allergy Asthma Immunol Res"},{"issue":"2","key":"jus230012r42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0301-2115(98)00061-X","article-title":"Periconceptional folic acid containing multivitamin supplementation.","volume":"78","author":"Czeizel","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"26","key":"jus230012r43","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1056\/NEJM199212243272602","article-title":"Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.","volume":"327","author":"Czeizel","year":"1992","journal-title":"N Engl J Med"},{"issue":"6893","key":"jus230012r44","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1136\/bmj.306.6893.1645","article-title":"Prevention of congenital abnormalities by periconceptional multivitamin supplementation.","volume":"306","author":"Czeizel","year":"1993","journal-title":"BMJ"},{"key":"jus230012r45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/nyas.1993.678.issue-1","article-title":"Controlled studies of multivitamin supplementation on pregnancy outcomes.","volume":"678","author":"Czeizel","year":"1993","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"jus230012r46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1096-8628(19960315)62:2<179::AID-AJMG12>3.0.CO;2-L","article-title":"Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation.","volume":"62","author":"Czeizel","year":"1996","journal-title":"Am J Med Genet"},{"issue":"3","key":"jus230012r47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF02390940","article-title":"Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation: final report.","volume":"255","author":"Czeizel","year":"1994","journal-title":"Arch Gynecol Obstet"},{"key":"jus230012r2","author":"Viswanathan","year":"2017"},{"key":"jus230012r4","author":"Viswanathan","year":"2023"},{"key":"jus230012r3","unstructured":"US Preventive Services Task Force Procedure Manual. US Preventive Services Task Force. Published May 2021. Accessed July 11, 2023. https:\/\/uspreventiveservicestaskforce.org\/uspstf\/about-uspstf\/methods-and-processes\/procedure-manual"},{"key":"jus230012r26","doi-asserted-by":"crossref","unstructured":"Ahrens? K, Yazdy? MM, Mitchell? AA, Werler? MM. Folic acid intake and spina bifida in the era of dietary folic acid fortification.? Epidemiology. 2011;22(5):731-737.  doi:10.1097\/EDE.0b013e318222788721659881","DOI":"10.1097\/EDE.0b013e3182227887"},{"key":"jus230012r41","doi-asserted-by":"crossref","unstructured":"Crider? KS, Cordero? AM, Qi? YP, Mulinare? J, Dowling? NF, Berry? RJ. Prenatal folic acid and risk of asthma in children: a systematic review and meta-analysis.? Am J Clin Nutr. 2013;98(5):1272-1281.  doi:10.3945\/ajcn.113.06562324004895","DOI":"10.3945\/ajcn.113.065623"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2807740\/jama_viswanathan_2023_us_230012_1690323428.74335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T11:01:36Z","timestamp":1690887696000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2807740"}},"subtitle":["Updated Evidence Report and Systematic Review for the US Preventive Services Task Force"],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.9864","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}